Mastoparan M Suppressed NLRP3 Inflammasome Activation by Inhibiting MAPK/NF-κB and Oxidative Stress in Gouty Arthritis

References

• Dalbeth N, Choi HK, Khanna PP, et al. Gout. Nat Rev Dis Primers. 2019;5(1):69.
   PubMedGoogle Scholar
• Dalbeth N, Gosling AL, Gaffo A, et al. Gout. Lancet. 2021;397(10287):1843–1855. doi:10.1016/S0140-6736(21)00569-9
   PubMed Web of Science ®Google Scholar
• Pillinger MH, Mandell BF. Therapeutic approaches in the treatment of gout. Semin Arthritis Rheum. 2020;50(3s):S24–s30. doi:10.1016/j.semarthrit.2020.04.010
   PubMed Web of Science ®Google Scholar
• Stamp LK, Farquhar H. Treatment advances in gout. Best practice & research. Clinical Rheumatol. 2021;35(4):101719. doi:10.1016/j.berh.2021.101719
   Web of Science ®Google Scholar
• Renaudin F, Orliaguet L, Castelli F, et al. Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages. Ann Rheum Dis. 2020;79(11):1506–1514. doi:10.1136/annrheumdis-2020-217342
   PubMed Web of Science ®Google Scholar
• Ostareck DH, Ostareck-Lederer A. RNA-binding proteins in the control of LPS-induced macrophage response. Front Genet. 2019;10:31. doi:10.3389/fgene.2019.00031
   PubMed Web of Science ®Google Scholar
• Li Z, Pan H, Yang J, et al. Xuanfei Baidu formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-κB and MAPK pathways in LPS-induced ALI and inflammation models. Phytomedicine. 2023;108:154545. doi:10.1016/j.phymed.2022.154545
   PubMed Web of Science ®Google Scholar
• Martinon F, Pétrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237–241. doi:10.1038/nature04516
   PubMed Web of Science ®Google Scholar
• Kingsbury SR, Conaghan PG, McDermott MF. The role of the NLRP3 inflammasome in gout. J Inflamm Res. 2011;4:39–49. doi:10.2147/JIR.S11330
   PubMedGoogle Scholar
• Liu HJ, Pan -X-X, Liu B-Q, et al. Grape seed-derived procyanidins alleviate gout pain via NLRP3 inflammasome suppression. J Neuroinflammation. 2017;14(1):74. doi:10.1186/s12974-017-0849-y
   PubMed Web of Science ®Google Scholar
• Cabău G, Crișan TO, Klück V, et al. Urate-induced immune programming: consequences for gouty arthritis and hyperuricemia. Immunol Rev. 2020;294(1):92–105. doi:10.1111/imr.12833
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu W, Lu D, et al. Tetrahydropalmatine attenuates MSU crystal-induced gouty arthritis by inhibiting ROS-mediated NLRP3 inflammasome activation. Int Immunopharmacol. 2021;100:108107. doi:10.1016/j.intimp.2021.108107
   PubMed Web of Science ®Google Scholar
• Wang M, Wu X-M, He M, et al. Mastoparan M extracted from Vespa magnifica alleviates neuronal death in global cerebral ischemia-reperfusion rat model. Iran J Basic Med Sci. 2022;25(3):320–329. doi:10.22038/IJBMS.2022.60745.13461
   PubMed Web of Science ®Google Scholar
• Moreno M, Giralt E. Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan. Toxins. 2015;7(4):1126–1150. doi:10.3390/toxins7041126
   PubMed Web of Science ®Google Scholar
• Gao Y, Yu W-X, Duan X-M, et al. Wasp venom possesses potential therapeutic effect in experimental models of rheumatoid arthritis. Evid Based Complement Alternat Med. 2020;2020:6394625. doi:10.1155/2020/6394625
   PubMed Web of Science ®Google Scholar
• Yun HS, Oh J, Lim JS, et al. Anti-inflammatory effect of wasp venom in BV-2 microglial cells in comparison with bee venom. Insects. 2021;12(4):297. doi:10.3390/insects12040297
   PubMed Web of Science ®Google Scholar
• Xu X, Yang H, Yu H, et al. The mastoparanogen from wasp. Peptides. 2006;27(12):3053–3057. doi:10.1016/j.peptides.2006.09.003
   PubMed Web of Science ®Google Scholar
• Li ML, Liao R-W, Qiu J-W, et al. Antimicrobial activity of synthetic all-D mastoparan M. Int J Antimicrob Agents. 2000;13(3):203–208. doi:10.1016/S0924-8579(99)00127-2
   PubMed Web of Science ®Google Scholar
• Mansour AA, Raucci F, Saviano A, et al. Galectin-9 regulates monosodium urate crystal-induced gouty inflammation through the modulation of Treg/Th17 Ratio. Front Immunol. 2021;12:762016. doi:10.3389/fimmu.2021.762016
   PubMed Web of Science ®Google Scholar
• Zhao W, Ma L, Cai C, et al. Caffeine inhibits NLRP3 inflammasome activation by suppressing MAPK/NF-κB and A2aR signaling in LPS-Induced THP-1 Macrophages. Int J Biol Sci. 2019;15(8):1571–1581. doi:10.7150/ijbs.34211
   PubMed Web of Science ®Google Scholar
• Xie D, Zhao H, Lu J, et al. High uric acid induces liver fat accumulation via ROS/JNK/AP-1 signaling. Am J Physiol Endocrinol Metab. 2021;320(6):E1032–e1043. doi:10.1152/ajpendo.00518.2020
   PubMed Web of Science ®Google Scholar
• Wood DD, Ihrie EJ, Dinarello CA, et al. Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum. 1983;26(8):975–983. doi:10.1002/art.1780260806
   PubMedGoogle Scholar
• Di Giovine FS, Malawista SE, Nuki G, et al. Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol. 1987;138(10):3213–3218. doi:10.4049/jimmunol.138.10.3213
   PubMed Web of Science ®Google Scholar
• Solomon DH, Glynn RJ, MacFadyen JG, et al. Relationship of interleukin-1β blockade with incident gout and serum uric acid levels: exploratory analysis of a randomized controlled trial. Ann Intern Med. 2018;169(8):535–542. doi:10.7326/M18-1167
   PubMed Web of Science ®Google Scholar
• Schlesinger N, Mysler E, Lin H-Y, et al. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study. Ann Rheum Dis. 2011;70(7):1264–1271. doi:10.1136/ard.2010.144063
   PubMed Web of Science ®Google Scholar
• Mei Y, Dong B, Geng Z, et al. Excess uric acid induces gouty nephropathy through crystal formation: a review of recent insights. Front Endocrinol. 2022;13:911968. doi:10.3389/fendo.2022.911968
   PubMed Web of Science ®Google Scholar
• An Y, Zhang H, Wang C, et al. Activation of ROS/MAPK s /NF- κ B/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. FASEB j. 2019;33(11):12515–12527. doi:10.1096/fj.201802805RR
   PubMed Web of Science ®Google Scholar
• Peng L, Wen L, Shi Q-F, et al. Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation. Cell Death Dis. 2020;11(11):978. doi:10.1038/s41419-020-03178-2
   PubMed Web of Science ®Google Scholar
• Fernando IPS, Dias MKHM, Madusanka DMD, et al. Low molecular weight fucoidan fraction ameliorates inflammation and deterioration of skin barrier in fine-dust stimulated keratinocytes. Int J Biol Macromol. 2021;168:620–630. doi:10.1016/j.ijbiomac.2020.11.115
   PubMed Web of Science ®Google Scholar
• Xiao Q, Piao R, Wang H, et al. Orientin-mediated Nrf2/HO-1 signal alleviates H(2)O(2)-induced oxidative damage via induction of JNK and PI3K/AKT activation. Int J Biol Macromol. 2018;118(Pt A):747–755. doi:10.1016/j.ijbiomac.2018.06.130
   PubMedGoogle Scholar
• Lin X, Wang H, An X, et al. Baeckein E suppressed NLRP3 inflammasome activation through inhibiting both the priming and assembly procedure: implications for gout therapy. Phytomedicine. 2021;84:153521. doi:10.1016/j.phymed.2021.153521
   PubMed Web of Science ®Google Scholar
• Ouyang X, Li N-Z, Guo M-X, et al. Active flavonoids from lagotis brachystachya attenuate monosodium urate-induced gouty arthritis via inhibiting TLR4/MyD88/NF-κB Pathway and NLRP3 expression. Front Pharmacol. 2021;12:760331. doi:10.3389/fphar.2021.760331
   PubMed Web of Science ®Google Scholar
• Abd El-Wahed A, Yosri N, Sakr HH, et al. Wasp venom biochemical components and their potential in biological applications and nanotechnological interventions. Toxins. 2021;13(3):206. doi:10.3390/toxins13030206
   PubMed Web of Science ®Google Scholar
• Zhao H, Wang M, Huang X, et al. Wasp venom from Vespa magnifica acts as a neuroprotective agent to alleviate neuronal damage after stroke in rats. Pharm Biol. 2022;60(1):334–346. doi:10.1080/13880209.2022.2032207
   PubMed Web of Science ®Google Scholar
• Liu Z, Yao X, Jiang W, et al. Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-κB signaling pathway and pyroptosis after secondary spinal cord injury. J Neuroinflammation. 2020;17(1):90. doi:10.1186/s12974-020-01751-2
   PubMed Web of Science ®Google Scholar
• Fann DY-W, Lim Y-A, Cheng Y-L, et al. Evidence that NF-κB and MAPK signaling promotes NLRP inflammasome activation in neurons following ischemic stroke. Mol Neurobiol. 2018;55(2):1082–1096. doi:10.1007/s12035-017-0394-9
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. NF-κB in immunobiology. Cell Res. 2011;21(2):223–244. doi:10.1038/cr.2011.13
   PubMed Web of Science ®Google Scholar
• Perkins ND. The diverse and complex roles of NF-κB subunits in cancer. Nat Rev Cancer. 2012;12(2):121–132.
   PubMed Web of Science ®Google Scholar
• Arthur JS, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 2013;13(9):679–692.
   PubMed Web of Science ®Google Scholar
• Wang M, Xu H, Chong Lee Shin OL, et al. Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways. J Transl Med. 2019;17(1):122.
   PubMedGoogle Scholar
• Yin C, Liu B, Wang P, et al. Eucalyptol alleviates inflammation and pain responses in a mouse model of gout arthritis. Br J Pharmacol. 2020;177(9):2042–2057. doi:10.1111/bph.14967
   PubMed Web of Science ®Google Scholar
• Abais JM, Xia M, Zhang Y, et al. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Antioxid Redox Signal. 2015;22(13):1111–1129. doi:10.1089/ars.2014.5994
   PubMed Web of Science ®Google Scholar
• Zhang H, Davies KJA, Forman HJ. Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med. 2015;88:314–336. doi:10.1016/j.freeradbiomed.2015.05.036
   PubMed Web of Science ®Google Scholar
• Zhou Y, Gao C, Vong CT, et al. Rhein regulates redox-mediated activation of NLRP3 inflammasomes in intestinal inflammation through macrophage-activated crosstalk. Br J Pharmacol. 2022;179(9):1978–1997. doi:10.1111/bph.15773
   PubMed Web of Science ®Google Scholar